b.perrin
Submits third-party assay reports on material purchased directly. Based in Malmö.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
99.43%
n=8
Suppliers covered
7
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041778 | SS-31 (Elamipretide) | FGP | FGP-2601-R1916 | VendorInvestigate | 2026-Q2 | 99.42 | 4.05 | 90.3 | Buyer-sourced | 0 | PASS |
| AX-2026-042383 | Tirzepatide | SWB | SWB-2601-V4383 | Kestrel | 2026-Q1 | 99.54 | 4.91 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019062 | Liraglutide | JEEP | JEEP-2411-B3841 | Janoshik | 2025-Q2 | 99.44 | 4.98 | 105.8 | Supplier-supplied | 0 | PASS |
| AX-2025-020505 | SS-31 (Elamipretide) | KP | KP-2408-H6177 | Medutest | 2025-Q1 | 99.04 | 3.66 | 96.1 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019514 | Humanin (HNG) | Homopeptide | HOMO-2408-A1230 | Janoshik | 2025-Q1 | 99.74 | 5.87 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2024-005029 | Semaglutide | GGPeps | GGPE-2410-L1879 | Medutest | 2024-Q4 | 98.22 | 4.03 | 91.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004812 | SS-31 (Elamipretide) | Homopeptide | HOMO-2410-K1981 | Janoshik | 2024-Q4 | 99.93 | 3.72 | — | Supplier-supplied | 0 | PASS |
| AX-2024-005352 | N-Acetyl Semax Amide | SGN | SGN-2407-R9967 | VendorInvestigate | 2024-Q3 | 97.31 | 7.98 | — | Buyer-sourced | 1 | FAIL |